Answer
Remimazolam besylate produces sedation by binding with high affinity to benzodiazepine sites on gamma-aminobutyric acid type A (GABAA) receptors; its CNS effects depend on the intravenous dose and other medicines present.
Sources for this answer
- Byfavo 20mg powder for solution for injectionPAION UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked